AIM
CORZ icon

Aigen Investment Management’s Core Scientific CORZ Stock Holding History

Aigen Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,038
Closed -$275K – 833
2025
Q1 		$275K Buy
+38,038
New +$433K 0.04% 529

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Aigen Investment Management's CORZ Position: Q2 2025 in Review

Aigen Investment Management sold out of Core Scientific (CORZ) in Q2 2025, closing a stake of 38,038 shares — an estimated $275K sold.

Aigen Investment Management first reported a position in CORZ in Q1 2025 and held it in 1 quarter. The position peaked at $275K in Q1 2025. 370 funds tracked by Wall St. Rank hold CORZ as of Q2 2025.

  • Aigen Investment Management reported no remaining Core Scientific position as of Q2 2025 after selling out during the quarter.
  • Aigen Investment Management sold 38,038 Core Scientific shares in Q2 2025, an estimated $275K.
  • Aigen Investment Management first reported a position in Core Scientific in Q1 2025 and held it in 1 quarter.
  • Aigen Investment Management's Core Scientific position peaked at $275K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held Core Scientific as of Q2 2025.

Based on Aigen Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.